Inventor · disambiguated record
Srinivasa R. Cheruku
Also filed as: CHERUKU SRINIVASA · CHERUKU SRINIVASA R · CHERUKU SRINIVASA RAO
19 granted patents·10 pending applications·117 citations·filing 2003–2023
93Inventor score
Files withEPIX PHARM INC6EPIX DELAWARE INC4NBD NANOTECHNOLOGIES INC4DHANOA DALE S3WARNER BABCOCK INST FOR GREEN CHEMISTRY LLC3
Top patents by PatentIndex Score
29 records- 0192US10442823B2Functionalized F-POSS monomer compositions and uses thereofNBD NANOTECHNOLOGIES INC·Filed 2017·Granted Oct 15, 2019·4 cites·20 claims
- 0288US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 0387US10174059B2Functionalized F-POSS monomer compositions and uses thereofNBD NANOTECHNOLOGIES INC·Filed 2016·Granted Jan 8, 2019·4 cites·20 claims
- 0487US7153858B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2004·Granted Dec 26, 2006·27 cites·57 claims
- 0586US7968538B2Substituted arylamine compounds and methods of treatmentGALENEA CORP·Filed 2006·Granted Jun 28, 2011·17 cites·60 claims
- 0683US7030240B2Piperidinylamino-thieno[2,3-d] pyrimidine compoundsPREDIX PHARMACEUTICALS HOLDING·Filed 2004·Granted Apr 18, 2006·34 cites·22 claims
- 0780US2023357288A1Functionalized f-poss monomer compositions and uses thereofHENKEL AG & CO KGAA·Filed 2023·Application pending·0 cites
- 0879US7488731B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2007·Granted Feb 10, 2009·3 cites·9 claims
- 0977US7855193B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2006·Granted Dec 21, 2010·3 cites·11 claims
- 1076US7790707B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Sep 7, 2010·2 cites·11 claims
- 1174US7612078B2Piperidinylamino-thieno[2,3-D] pyrimidine compoundsEPIX DELAWARE INC·Filed 2005·Granted Nov 3, 2009·2 cites·16 claims
- 1272US7491727B2Arylpiperazinyl compoundsEPIX DELAWARE INC·Filed 2006·Granted Feb 17, 2009·1 cites·8 claims
- 1371US8604021B2Substituted arylamine compounds and methods of treatmentBECKER OREN·Filed 2011·Granted Dec 10, 2013·3 cites·15 claims
- 1469US11702433B2Functionalized F-POSS monomer compositions and uses thereofNBD NANOTECHNOLOGIES INC·Filed 2019·Granted Jul 18, 2023·0 cites·15 claims
- 1568US10590100B2Benzofuran derivatives for the treatment of CNS and other disordersWARNER BABCOCK INST FOR GREEN CHEMISTRY·Filed 2016·Granted Mar 17, 2020·2 cites·14 claims
- 1662US11266686B2Metal complexes and methods of treatmentPROCYPRA THERAPEUTICS LLC·Filed 2014·Granted Mar 8, 2022·1 cites·4 claims
- 1758US2010113485A1Piperidinylamino-thieno[2,3-D] Pyrimidine CompoundsDHANOA DALE S·Filed 2009·Application pending·0 cites
- 1850US2005222175A1New piperidinylamino-thieno[2,3-D] pyrimidine compoundsDHANOA DALE S·Filed 2004·Application pending·0 cites
- 1948US11352554B2Photochromic water harvesting platformWARNER BABCOCK INST FOR GREEN CHEMISTRY LLC·Filed 2017·Granted Jun 7, 2022·0 cites·5 claims
- 2044US2010317649A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2010·Application pending·0 cites
- 2144US2011212940A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2011·Application pending·0 cites
- 2243US9394299B2Rilyazine derivatives and compositions for the treatment of cancerWARNER BABCOCK INST FOR GREEN CHEMISTRY LLC·Filed 2014·Granted Jul 19, 2016·0 cites·9 claims
- 2343US2011059945A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2010·Application pending·0 cites
- 2441US2019152993A1Reversibly Switchable Surfactants and Methods of UseWARNER BABCOCK INST FOR GREEN CHEMISTRY LLC·Filed 2017·Application pending·0 cites
- 2540US2011082157A1Piperidinylamino-Thieno [2,3-D] Pyrimidine CompoundsDHANOA DALE S·Filed 2010·Application pending·0 cites
- 2640US2004138238A1Substituted aminopyrimidine compounds as neurokinin antagonistsFiled 2003·Application pending·0 cites
- 2737US9630981B2Processes for preparing functionalized F-POSS monomersNBD NANOTECHNOLOGIES INC·Filed 2016·Granted Apr 25, 2017·0 cites·20 claims
- 2837US2022144826A1Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related DisordersCOLLABORATIVE MEDICINAL DEV LLC·Filed 2020·Application pending·0 cites
- 2932US10047089B2Dihydro-6-azaphenalene derivatives for the treatment of CNS, oncological diseases and related disordersCOLLABORATIVE MEDICINAL DEV LLC·Filed 2013·Granted Aug 14, 2018·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →